Skip to main content
LobbyMap

Vanguard Pharma Corporation

Defense & Aerospace · Lobbying Client

C
Influence Score
45/100
Moderate Influence
$2.7M
Total Lobby Spend
5
Policy Issues
1
Lobbyists
0
Revolving Door

Vanguard Pharma Corporation reported $2.7 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 5 policy areas, with primary focus on Defense, Aerospace, Budget/Appropriations. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Centers for Medicare & Medicaid Services
Dept of Commerce
Securities & Exchange Commission
Dept of Health & Human Services
Federal Energy Regulatory Commission
Dept of Agriculture

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2020 Jan-MarBGR Group LLP
FIRAERDEF
1$195K
2020 Apr-JunK&L Gates LLP
FIR
1$161K
2020 Jul-SepHolland & Knight LLP
AERDEF
1$162K
2020 Oct-DecBrownstein Hyatt LLP
BUDDEFFIR
1$159K
2021 Jan-MarBrownstein Hyatt LLP
DEF
1$89K
2021 Apr-JunBGR Group LLP
FIR
1$71K
2021 Jul-SepAkin Gump LLP
DEFGOV
1$101K
2021 Oct-DecHolland & Knight LLP
AERGOVFIR+2
1$72K

Vanguard Pharma Corporation Lobbying FAQ

Vanguard Pharma Corporation has spent $2.7M on federal lobbying across 5 policy areas. This includes spending on registered lobbyists and direct government contacts.

Vanguard Pharma Corporation lobbies on 5 policy issues, including Defense, Aerospace, Budget/Appropriations, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Vanguard Pharma Corporation has an Influence Score of 45/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Vanguard Pharma Corporation employs 1 registered lobbyists, of whom 0 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Vanguard Pharma Corporation has contacted 6 government entities as part of their lobbying activities, including Centers for Medicare & Medicaid Services, Dept of Commerce, Securities & Exchange Commission.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.